Breast Carcinomas with Equivocal HER2/Neu Amplification: Morphologic Features, CEP17 Polysomy and HER2 Genetic Heterogeneity

被引：0
|
作者：
Astvatsaturyan, K. [1 ]
Bose, S. [1 ]
机构：
[1] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA
来源：
LABORATORY INVESTIGATION | 2012年 / 92卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
91
引用
收藏
页码：24A / 25A
页数：2
相关论文
共 50 条
  • [11] CEP17 "Polysomy" (CEP17P): Definition and Impact on HER2 Copy Number (CN) in Breast Carcinoma
    Astvatsaturyan, K.
    Mirocha, J.
    Bose, S.
    MODERN PATHOLOGY, 2012, 25 : 24A - 24A
  • [12] Breast Cancers with < 4 HER2 Signals/cell and Amplified HER2:CEP17 Ratios by FISH: Pathologic Features and Clinical Outcomes of Cases with "CEP17 Monosomy"
    Ballard, Morgan
    Troxell, Megan
    Jensen, Kristin
    Allison, Kimberly H.
    LABORATORY INVESTIGATION, 2017, 97 : 31A - 31A
  • [13] Breast Cancers with < 4 HER2 Signals/cell and Amplified HER2:CEP17 Ratios by FISH: Pathologic Features and Clinical Outcomes of Cases with "CEP17 Monosomy"
    Ballard, Morgan
    Troxell, Megan
    Jensen, Kristin
    Allison, Kimberly H.
    MODERN PATHOLOGY, 2017, 30 : 31A - 31A
  • [14] Breast Cancers with HER2 and CEP17 "Co-Amplification" by FISH: Pathologic Features and Clinical Outcomes
    Ballard, Morgan
    Troxell, Megan
    Jensen, Kristin
    Allison, Kimberly H.
    MODERN PATHOLOGY, 2017, 30 : 31A - 31A
  • [15] Breast Cancers with HER2 and CEP17 "Co-Amplification" by FISH: Pathologic Features and Clinical Outcomes
    Ballard, Morgan
    Troxell, Megan
    Jensen, Kristin
    Allison, Kimberly H.
    LABORATORY INVESTIGATION, 2017, 97 : 31A - 31A
  • [16] Amplification of Chromosome 17 Centromere (CEP17) in Breast Cancer Patients with a Result of HER2 2± by Immunohistochemistry
    Davies, Vanessa
    Voutsadakis, Ioannis A.
    CANCER INVESTIGATION, 2020, 38 (02) : 94 - 101
  • [17] High HER2 signals and HER2/CEP17 ratio tumours achieve better responses in breast cancer
    Exposito Afonso, I. J.
    del Pino Sedeno, T.
    Gonzalez Villa, I.
    Loro Ferrer, J. F.
    Cabrera Galvan, J. J.
    VIRCHOWS ARCHIV, 2020, 477 : S45 - S46
  • [18] Is "Polysomy" in Breast Carcinoma the "New Equivocal" in HER2 Testing?
    Swanson, Paul E.
    Yang, Hua
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2015, 144 (02) : 181 - 184
  • [19] Association between HER2 positivity by HER2/CEP17 ratio and response to neoadjuvant HER2 targeted therapy.
    Rappazzo, Katherine Cynthia
    Chen, Heidi
    Ballinger, Tarah Jean
    Abramson, Vandana Gupta
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [20] Relationship between Pathological Features, Her2 Protein Expression, and HER2 and CEP17 Copy Numbers in DCIS.
    Lambein, K.
    Van Bockstal, M.
    Praet, M.
    Denys, H.
    Braems, G.
    Nuyts, A.
    Cocquyt, V.
    Pauweis, P.
    Van Den Broecke, R.
    Libbrecht, L.
    CANCER RESEARCH, 2011, 71
12345